261 related articles for article (PubMed ID: 17383632)
1. Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help.
Garay RP; Viens P; Bauer J; Normier G; Bardou M; Jeannin JF; Chiavaroli C
Eur J Pharmacol; 2007 Jun; 563(1-3):1-17. PubMed ID: 17383632
[TBL] [Abstract][Full Text] [Related]
2. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
3. Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells.
Hirata N; Yanagawa Y; Ebihara T; Seya T; Uematsu S; Akira S; Hayashi F; Iwabuchi K; Onoé K
Mol Immunol; 2008 May; 45(10):2734-42. PubMed ID: 18372043
[TBL] [Abstract][Full Text] [Related]
4. TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages.
Arko-Mensah J; Julián E; Singh M; Fernández C
Scand J Immunol; 2007 Feb; 65(2):148-57. PubMed ID: 17257219
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells.
Uno K; Kato K; Atsumi T; Suzuki T; Yoshitake J; Morita H; Ohara S; Kotake Y; Shimosegawa T; Yoshimura T
Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G1004-12. PubMed ID: 17855767
[TBL] [Abstract][Full Text] [Related]
6. TLR2 and TLR4 agonists synergistically up-regulate SR-A in RAW264.7 through p38.
Xu WY; Wang L; Wang HM; Wang YQ; Liang YF; Zhao TT; Wu YZ
Mol Immunol; 2007 Mar; 44(9):2315-23. PubMed ID: 17173973
[TBL] [Abstract][Full Text] [Related]
7. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
[TBL] [Abstract][Full Text] [Related]
8. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P
Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025
[TBL] [Abstract][Full Text] [Related]
10. The shiitake mushroom-derived immuno-stimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive immune-responses.
Zhou LD; Zhang QH; Zhang Y; Liu J; Cao YM
Int Immunopharmacol; 2009 Apr; 9(4):455-62. PubMed ID: 19189863
[TBL] [Abstract][Full Text] [Related]
11. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor.
Ward JR; Bingle L; Judge HM; Brown SB; Storey RF; Whyte MK; Dower SK; Buttle DJ; Sabroe I
Thromb Haemost; 2005 Oct; 94(4):831-8. PubMed ID: 16270639
[TBL] [Abstract][Full Text] [Related]
12. Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors.
Murata M
Cancer Sci; 2008 Jul; 99(7):1435-40. PubMed ID: 18452561
[TBL] [Abstract][Full Text] [Related]
13. Rho proteins are negative regulators of TLR2, TLR3, and TLR4 signaling in astrocytes.
Borysiewicz E; Fil D; Konat GW
J Neurosci Res; 2009 May; 87(7):1565-72. PubMed ID: 19115402
[TBL] [Abstract][Full Text] [Related]
14. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors and agonist responses in the developing fetal sheep lung.
Hillman NH; Moss TJ; Nitsos I; Kramer BW; Bachurski CJ; Ikegami M; Jobe AH; Kallapur SG
Pediatr Res; 2008 Apr; 63(4):388-93. PubMed ID: 18356744
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the expression of Toll-like receptor 2 and 4 in mononuclear cells and postoperative acute lung injury in orthotopic liver transplantation.
Chi XJ; Cai J; Luo CF; Cheng N; Hei ZQ; Li SR; Luo GJ
Chin Med J (Engl); 2009 Apr; 122(8):895-9. PubMed ID: 19493410
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.
Vanhoutte F; Paget C; Breuilh L; Fontaine J; Vendeville C; Goriely S; Ryffel B; Faveeuw C; Trottein F
Immunol Lett; 2008 Feb; 116(1):86-94. PubMed ID: 18166232
[TBL] [Abstract][Full Text] [Related]
18. TLR activation induces TNF-alpha production from adult neural stem/progenitor cells.
Covacu R; Arvidsson L; Andersson A; Khademi M; Erlandsson-Harris H; Harris RA; Svensson MA; Olsson T; Brundin L
J Immunol; 2009 Jun; 182(11):6889-95. PubMed ID: 19454685
[TBL] [Abstract][Full Text] [Related]
19. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop.
Wenink MH; Santegoets KC; Broen JC; van Bon L; Abdollahi-Roodsaz S; Popa C; Huijbens R; Remijn T; Lubberts E; van Riel PL; van den Berg WB; Radstake TR
J Immunol; 2009 Dec; 183(11):6960-70. PubMed ID: 19915052
[TBL] [Abstract][Full Text] [Related]
20. TLR2 and TLR4 agonists induce production of the vasoactive peptide endothelin-1 by human dendritic cells.
Spirig R; Potapova I; Shaw-Boden J; Tsui J; Rieben R; Shaw SG
Mol Immunol; 2009 Sep; 46(15):3178-82. PubMed ID: 19559483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
